Delivery Order SPE2DB22D3301-SPE2DB25FX8JG

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,057.92, is a Firm Fixed Price Delivery Order for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,389.85 firm fixed-price delivery order contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML medical supplies. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,197.84 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,050.18, is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.38 firm fixed-price delivery order is for the supply of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a period of performance through October 2024. This contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen holds a significant $999,999,999...
This federal contract award is an order placed under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,498.20, is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical pharmaceutical product. The contract has a February 2024 completion date and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the U.S. Department of Defense (DoD) Medical Supply Chain for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The $6,867.92 delivery order contract is a firm fixed-price arrangement without any set-aside designation. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical to...
This federal contract award, with a value of $1,726.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has a period of performance through June 25, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating the contract was competed openly....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the medical product "OMNIPAQUE 350 MG/ML PLUSPAK 500ML" and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a specialty pharmaceutical product. The $1,808.46 firm fixed-price delivery order contract has a completion date of June 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8JG
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price of $1,690.80 and a period of performance through January 14, 2025. The contract is not designated as a set-aside award.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 4/14/25, 10:34 AM